Steven Cohen Theravance Biopharma, Inc. Transaction History

Point72 Asset Management, L.P.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$8.41 - $10.34 $4.63 Million - $5.69 Million	-550,200 Reduced 83.86%	105,900 $959,000
Q1 2022 May 16, 2022	BUY	$8.33 - $12.96 $4.26 Million - $6.62 Million	511,000 Added 352.17%	656,100 $6.27 Million
Q4 2021 Feb 14, 2022	SELL	$7.42 - $11.05 $24.2 Million - $36 Million	-3,260,502 Reduced 95.74%	145,100 $1.6 Million
Q3 2021 Nov 15, 2021	BUY	$6.77 - $14.41 $23.1 Million - $49.1 Million	3,405,602 New	3,405,602 $25.2 Million

122

47.3M

200

12.8K

Ticker TBPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,782,400
Market Cap $640M
Description
Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States, Europe, and Asia. The company offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist used for the treatment of chronic obstructive pulmonary disease (COPD). Its product portfolio also inc...

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.